VolitionRx Limited (VNRX)
Largest Insider Buys in Sector
VNRX Stock Price History Chart
VNRX Stock Performance
About VolitionRx Limited
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
Insider Activity of VolitionRx Limited
Over the last 12 months, insiders at VolitionRx Limited have bought $194,761 and sold $33,000 worth of VolitionRx Limited stock.
On average, over the past 5 years, insiders at VolitionRx Limited have bought $628,937 and sold $385,650 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Micallef Jacob Vincent (Chief Scientific Officer) — $49,863. Innes Guy Archibald (director) — $37,200. Butera Salvatore Thomas (CEO - Volition Veterinary) — $33,780.
The last purchase of 10,000 shares for transaction amount of $8,300 was made by Butera Salvatore Thomas (CEO ‑ Volition Veterinary) on 2023‑12‑18.
List of Insider Buy and Sell Transactions, VolitionRx Limited
| 2024-01-02 | Sale | Eight Corp Ltd | 10 percent owner | 20,000 0.0222% | $0.90 | $18,000 | -19.94% | |
| 2023-12-18 | Butera Salvatore Thomas | CEO - Volition Veterinary | 10,000 0.0135% | $0.83 | $8,300 | +6.75% | ||
| 2023-12-15 | Sale | Eight Corp Ltd | 10 percent owner | 20,000 0.0244% | $0.75 | $15,000 | +7.37% | |
| 2023-12-15 | Butera Salvatore Thomas | CEO - Volition Veterinary | 10,000 0.0125% | $0.77 | $7,700 | +7.37% | ||
| 2023-12-13 | Rootsaert Rodney Gerard | Secretary | 10,000 0.0133% | $0.60 | $6,000 | +40.62% | ||
| 2023-12-08 | Reynolds Cameron John | President and CEO | 10,000 0.0131% | $0.67 | $6,700 | +23.08% | ||
| 2023-11-27 | Innes Guy Archibald | director | 20,000 0.0247% | $0.77 | $15,400 | +1.58% | ||
| 2023-11-27 | Futcher Edward | director | 9,000 0.0115% | $0.80 | $7,200 | +1.58% | ||
| 2023-11-24 | Innes Guy Archibald | director | 10,000 0.013% | $0.76 | $7,600 | +4.87% | ||
| 2023-11-22 | Innes Guy Archibald | director | 20,000 0.0252% | $0.71 | $14,200 | +7.74% | ||
| 2023-11-16 | Butera Salvatore Thomas | CEO - Volition Veterinary | 10,000 0.0134% | $0.81 | $8,100 | +0.33% | ||
| 2023-09-05 | Barnes Phillip | director | 5,000 0.0066% | $1.30 | $6,500 | -37.87% | ||
| 2023-08-31 | Faulkes Martin Charles | director | 9,716 0.0127% | $1.28 | $12,436 | -38.23% | ||
| 2023-08-31 | Henshall Mickie | director | 3,706 0.0047% | $1.25 | $4,633 | -38.23% | ||
| 2023-08-30 | Micallef Jacob Vincent | Chief Scientific Officer | 8,750 0.0113% | $1.27 | $11,113 | -37.66% | ||
| 2023-08-29 | Micallef Jacob Vincent | Chief Scientific Officer | 11,250 0.0142% | $1.24 | $13,950 | -38.41% | ||
| 2023-08-25 | Micallef Jacob Vincent | Chief Scientific Officer | 20,000 0.0258% | $1.24 | $24,800 | -36.00% | ||
| 2023-08-24 | Michel Gaetan | Chief Operating Officer | 5,000 0.0064% | $1.23 | $6,150 | -34.22% | ||
| 2023-08-24 | Futcher Edward | director | 5,000 0.0063% | $1.22 | $6,100 | -34.22% | ||
| 2023-08-24 | Kway Jasmine | CEO - Singapore Volition | 5,000 0.0062% | $1.20 | $6,000 | -34.22% |
Insider Historical Profitability
| Reynolds Cameron John | President and CEO | 1704518 2.1662% | $0.61 | 8 | 2 | +12.08% |
| Faulkes Martin Charles | director | 1673532 2.1269% | $0.61 | 7 | 1 | +10.96% |
| Innes Guy Archibald | director | 627161 0.797% | $0.61 | 10 | 0 | <0.0001% |
| Eight Corp Ltd | 10 percent owner | 298419 0.3793% | $0.61 | 1 | 3 | <0.0001% |
| Michel Gaetan | Chief Operating Officer | 212997 0.2707% | $0.61 | 1 | 0 | |
| Butera Salvatore Thomas | CEO - Volition Veterinary | 99350 0.1263% | $0.61 | 13 | 0 | <0.0001% |
| Rootsaert Rodney Gerard | Secretary | 78652 0.1% | $0.61 | 3 | 1 | +31.58% |
| Futcher Edward | director | 71936 0.0914% | $0.61 | 2 | 0 | |
| Micallef Jacob Vincent | Chief Scientific Officer | 55000 0.0699% | $0.61 | 7 | 0 | <0.0001% |
| Barnes Phillip | director | 24686 0.0314% | $0.61 | 1 | 0 | |
| Henshall Mickie | director | 18706 0.0238% | $0.61 | 1 | 0 | |
| Kway Jasmine | CEO - Singapore Volition | 10400 0.0132% | $0.61 | 1 | 0 | |
| THACHUK E DEL | CEO and President | 100000 0.1271% | $0.61 | 1 | 0 | |
| Colman Alan | director | 53937 0.0685% | $0.61 | 1 | 0 | |
| Plummer Nicholas | GC - Volition Diagnostics | 51494 0.0654% | $0.61 | 1 | 0 | <0.0001% |
| Brooke Brian Gordon | Chief Financial Officer | 50000 0.0635% | $0.61 | 1 | 0 | |
| THACHUK MARY ANNE | Secretary Treasurer | 20000 0.0254% | $0.61 | 1 | 0 | |
| TERRELL JASON BRADLEY MD | Chief Medical Officer | 12300 0.0156% | $0.61 | 0 | 8 | |
| KRATOCHVIL DAVID MATTHEW | Chief Financial Officer | 10000 0.0127% | $0.61 | 1 | 0 | <0.0001% |
| Vanston David Cecil | CHIEF FINANCIAL OFFICER | 2750 0.0035% | $0.61 | 1 | 0 | <0.0001% |
| Nguyen Kim | director | 2500 0.0032% | $0.61 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| LAGODA INVESTMENT MANAGEMENT, LP | $3.84M | 6.13 | 5.07M | +36.06% | +$1.02M | 2.36 | |
| The Vanguard Group | $481,579.00 | 0.77 | 636,167 | +1.04% | +$4,941.70 | <0.0001 | |
| Geode Capital Management | $467,464.00 | 0.75 | 617,366 | +10.76% | +$45,395.87 | <0.0001 | |
| BlackRock | $434,336.00 | 0.69 | 573,760 | -0.55% | -$2,395.15 | <0.0001 | |
| Bridgeway Capital Management | $131,854.00 | 0.21 | 174,180 | -1.09% | -$1,453.44 | <0.01 | |
| Morgan Stanley | $101,438.00 | 0.16 | 134,000 | -1.27% | -$1,308.85 | <0.0001 | |
| State Street | $93,810.00 | 0.15 | 123,923 | 0% | +$0 | <0.0001 | |
| Northern Trust | $67,667.00 | 0.11 | 89,389 | -0.17% | -$118.85 | <0.0001 | |
| Spectrum Asset Management | $42,087.00 | 0.07 | 55,596 | 0% | +$0 | 0.02 | |
| Susquehanna International Group | $37,908.00 | 0.06 | 50,076 | New | +$37,908.00 | <0.0001 | |
| Advisor Group Holdings Inc | $22,814.00 | 0.04 | 30,020 | +55.38% | +$8,131.57 | <0.0001 | |
| UBS | $21,543.00 | 0.03 | 28,458 | +912.02% | +$19,414.29 | <0.0001 | |
| TWO SIGMA SECURITIES LLC | $17,170.00 | 0.03 | 22,682 | +93% | +$8,273.88 | <0.0001 | |
| Charles Schwab | $11,646.00 | 0.02 | 15,384 | 0% | +$0 | <0.0001 | |
| Qube Research & Technologies | $4,802.00 | 0.01 | 6,344 | 0% | +$0 | <0.0001 | |
| Hartford Financial Management Inc | $3,785.00 | 0.01 | 5,000 | 0% | +$0 | <0.01 | |
| Tower Research Capital | $1,912.00 | <0.01 | 2,526 | -81.84% | -$8,617.63 | <0.0001 | |
| Founders Capital Management | $1,514.00 | <0.01 | 2,000 | 0% | +$0 | <0.01 | |
| Simplex Trading Llc | $0 | <0.01 | 475 | New | +$0 | <0.0001 | |
| Wells Fargo | $359.00 | <0.01 | 474 | +2.38% | +$8.33 | <0.0001 | |
| Allworth Financial Lp | $152.00 | <0.01 | 200 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 41 | -91.09% | -$0 | <0.0001 |